BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22369964)

  • 21. The FEMA GRAS assessment of benzyl derivatives used as flavor ingredients.
    Adams TB; Cohen SM; Doull J; Feron VJ; Goodman JI; Marnett LJ; Munro IC; Portoghese PS; Smith RL; Waddell WJ; Wagner BM;
    Food Chem Toxicol; 2005 Aug; 43(8):1207-40. PubMed ID: 15950815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The FEMA GRAS assessment of hydroxy- and alkoxy-substituted benzyl derivatives used as flavor ingredients.
    Adams TB; Cohen SM; Doull J; Feron VJ; Goodman JI; Marnett LJ; Munro IC; Portoghese PS; Smith RL; Waddell WJ; Wagner BM;
    Food Chem Toxicol; 2005 Aug; 43(8):1241-71. PubMed ID: 15950816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The FEMA GRAS assessment of alpha,beta-unsaturated aldehydes and related substances used as flavor ingredients.
    Adams TB; Gavin CL; Taylor SV; Waddell WJ; Cohen SM; Feron VJ; Goodman J; Rietjens IM; Marnett LJ; Portoghese PS; Smith RL
    Food Chem Toxicol; 2008 Sep; 46(9):2935-67. PubMed ID: 18644420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety evaluation of food flavorings.
    Schrankel KR
    Toxicology; 2004 May; 198(1-3):203-11. PubMed ID: 15138043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
    Powley MW
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The FEMA GRAS assessment of aliphatic and aromatic terpene hydrocarbons used as flavor ingredients.
    Adams TB; Gavin CL; McGowen MM; Waddell WJ; Cohen SM; Feron VJ; Marnett LJ; Munro IC; Portoghese PS; Rietjens IM; Smith RL
    Food Chem Toxicol; 2011 Oct; 49(10):2471-94. PubMed ID: 21726592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictivity and reliability of QSAR models: the case of mutagens and carcinogens.
    Benigni R; Bossa C
    Toxicol Mech Methods; 2008; 18(2-3):137-47. PubMed ID: 20020910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the OECD (Q)SAR Application Toolbox and Toxtree for predicting and profiling the carcinogenic potential of chemicals.
    Mombelli E; Devillers J
    SAR QSAR Environ Res; 2010 Oct; 21(7-8):731-52. PubMed ID: 21120759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavouring agents.
    Renwick AG
    Toxicol Lett; 2004 Apr; 149(1-3):223-34. PubMed ID: 15093268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbamates and ICH M7 classification: Making use of expert knowledge.
    Hemingway R; Fowkes A; Williams RV
    Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR models to predict mutagenicity of acrylates, methacrylates and alpha,beta-unsaturated carbonyl compounds.
    Pérez-Garrido A; Helguera AM; Rodríguez FG; Cordeiro MN
    Dent Mater; 2010 May; 26(5):397-415. PubMed ID: 20122717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Searching for an enhanced predictive tool for mutagenicity.
    Klopman G; Zhu H; Fuller MA; Saiakhov RD
    SAR QSAR Environ Res; 2004 Aug; 15(4):251-63. PubMed ID: 15370416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A large comparison of integrated SAR/QSAR models of the Ames test for mutagenicity
    Benfenati E; Golbamaki A; Raitano G; Roncaglioni A; Manganelli S; Lemke F; Norinder U; Lo Piparo E; Honma M; Manganaro A; Gini G
    SAR QSAR Environ Res; 2018 Aug; 29(8):591-611. PubMed ID: 30052064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Halogenated derivatives QSAR model using spectral moments to predict haloacetic acids (HAA) mutagenicity.
    Pérez-Garrido A; González MP; Escudero AG
    Bioorg Med Chem; 2008 May; 16(10):5720-32. PubMed ID: 18406150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.
    Mayer J; Cheeseman MA; Twaroski ML
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):50-8. PubMed ID: 18023949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated approach to assess the domain of applicability of some commercial (Q)SAR models.
    Kulkarni SA; Zhu J
    SAR QSAR Environ Res; 2008; 19(1-2):39-54. PubMed ID: 18311633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
    Araya S; Lovsin-Barle E; Glowienke S
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.